Vimarsana
Biggest News Aggregation in the World

Page 29 - Expanded Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Expanded Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Expanded Program Today - Breaking & Trending Today

Malawi Launches Polio Vaccine for East and Southern Africa Countries - Vimarsana News

Malawi Launches Polio Vaccine for East and Southern Africa Countries

BLANTYRE, MALAWI - Malawi Sunday launched a polio vaccination campaign after the country in February confirmed its first case, 30 years after it era

Tracking Demographic Movements and Immunization Status to Improve Children's Access to Immunization: Field-Based Randomized Controlled Trial - Vimarsana News

Tracking Demographic Movements and Immunization Status to Improve Children's Access to Immunization: Field-Based Randomized Controlled Trial

"This strategy should be adopted to improve access to vaccination for EPI target populations and the consistency verified in other contexts." In Cameroon, many children are not vaccinated on time or do not complete their vaccination schedule as required by the national Expanded Program on Immunization (EPI), despite the fact that the EPI vaccinatio

School vaccination against covid and other diseases starts Mar.14 - Vimarsana News

School vaccination against covid and other diseases starts Mar.14

Mar 07, 2022 - Vaccination against covid-19 and other diseases will start in Panama schools on March 14, as part of the strategies to protect the population from the virus a

83.6 % of Panamanians have received Covid vaccine - Vimarsana News

83.6 % of Panamanians have received Covid vaccine

Feb 20, 2022 - A total of 7,499,942 doses of vaccines against Covid-19 have been applied in Panama, according to the report of the Expanded Program of Immunization of the Mi

Related Topics:
Expanded Program
Study shows immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in Congolese populations - Vimarsana News

Study shows immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in Congolese populations

A new study by UCLA researchers and colleagues demonstrates that the Ebola vaccine known as rVSVΔG-ZEBOV-GP results in a robust and enduring antibody response among vaccinated individuals in areas of the Democratic Republic of Congo (DRC) that are experiencing outbreaks of the disease.